Moderna MRNA earnings Q3 2021

Moderna’s signal is seen exterior of their headquarters in Cambridge, MA on March 11, 2021.

Boston Globe | Getty Photos

Moderna shares fell 8% on Thursday after it lower its Covid-19 vaccine gross sales forecast for the 12 months to between $15 billion and $18 billion from $20 billion.

This can be a creating story. Please test again for updates.

Source link


News7h: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button